ONL logo.jpg
ONL Therapeutics Closes First Tranche of $15 Million Series C Financing to Advance Lead Compound into Phase 2 Clinical Trial
March 08, 2023 07:00 ET | ONL Therapeutics
ANN ARBOR, Mich., March 08, 2023 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal...
ReportLinker logo.jpg
Ophthalmic Drugs Market Size, Share & Trends Analysis Report By Drug Class, By Disease, By Dosage Form, By Route of Administration, By Product Type, By Region And Segment Forecasts, 2022 - 2030
November 04, 2022 08:27 ET | ReportLinker
New York, Nov. 04, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Ophthalmic Drugs Market Size, Share & Trends Analysis Report By Drug Class, By Disease, By...
Hatch félicite les g
Hatch félicite les gouvernements du Canada et de l'Allemagne pour leur leadership dans le cadre de l'accélération de la transition mondiale vers des énergies propres et pour leurs annonces à propos des marchés des métaux des batteries et de l'hydrogène
September 01, 2022 06:00 ET | Hatch Ltd
MISSISSAUGA, Ontario, 01 sept. 2022 (GLOBE NEWSWIRE) -- Cette semaine, les gouvernements du Canada et de l’Allemagne se sont réunis pour discuter de deux domaines-clés de coopération au moment où...
Hatch_Logo_Colour_RGB.jpg
Hatch commends the governments of Canada and Germany for their leadership in accelerating the global clean energy transition with announcements for the battery metals and hydrogen markets
September 01, 2022 06:00 ET | Hatch Ltd
MISSISSAUGA, Ontario, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Last week, the governments of Canada and Germany came together to discuss two key areas of cooperation as we move towards a net-zero future,...
Iantrek logo and byline tight.jpg
Iantrek Raises $23M Series B Financing to Advance Next Generation Ophthalmic Micro-Interventional Technologies
August 30, 2022 08:00 ET | Iantrek, Inc.
WHITE PLAINS, N.Y., Aug. 30, 2022 (GLOBE NEWSWIRE) -- Iantrek, Inc., a medical device company founded by ophthalmic innovator Dr. Sean Ianchulev, announced the closing of a $23M Series B financing....
NEXT Canada 2
Hatch to work with NEXT Canada to accelerate Canadian AI founders
July 12, 2022 08:00 ET | Hatch Ltd
Mississauga, Canada, July 12, 2022 (GLOBE NEWSWIRE) -- Hatch is pleased to announce that it has teamed up with NEXT Canada, to support their Next AI program. Next AI is a founder-focused educational...
Judy Product Image
AaDya Security Lands $3.1M in Venture Funding to Accelerate Expansion in the SMB-Focused Cybersecurity Market
January 27, 2022 15:00 ET | AaDya Security
DETROIT, Jan. 27, 2022 (GLOBE NEWSWIRE) -- AaDya Security, a Detroit-based software company founded by cybersecurity veteran Raffaele Mautone in March of 2019, announced the close of a $3.1M funding...
Orasis Logo hires (2).png
Orasis Pharmaceuticals Appoints Julie Speed as Senior Vice President, Head of Strategy and Marketing to Lead Commercial Growth Plan
October 04, 2021 08:00 ET | Orasis Pharmaceuticals
HERZLIYA, Israel, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Orasis Pharmaceuticals, an emerging ophthalmic pharmaceutical company focused on developing an innovative pharmaceutical solution for the...
mobix labs logo.png
Mobix Labs Appoints Kurt Busch and Bill Carpou to Board of Directors
June 03, 2021 08:25 ET | Mobix Labs Inc.
IRVINE, Calif., June 03, 2021 (GLOBE NEWSWIRE) -- Mobix Labs Inc., a fabless RF (radio frequency) component company focused on next-generation wireless technologies, today announced the appointments...
Her Majesty Queen Máxima of the Netherlands Announced as the 2021 Financial Health Visionary Award Recipient
May 18, 2021 08:47 ET | Financial Health Network
Chicago, IL, May 18, 2021 (GLOBE NEWSWIRE) -- Financial Health Network, the leading authority on financial health, today announced that H.M. Queen Máxima of the Netherlands, United Nations...